Cargando…

Nonoptimal Vaginal Microbiota After Azithromycin Treatment for Chlamydia trachomatis Infection

We characterized the composition and structure of the vaginal microbiota in a cohort of 149 women with genital Chlamydia trachomatis infection at baseline who were followed quarterly for 9 months after antibiotic treatment. At time of diagnosis, the vaginal microbiota was dominated by Lactobacillus...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamarelle, Jeanne, Ma, Bing, Gajer, Pawel, Humphrys, Mike S, Terplan, Mishka, Mark, Katrina S, Thiébaut, Anne C M, Forney, Larry J, Brotman, Rebecca M, Delarocque-Astagneau, Elisabeth, Bavoil, Patrik M, Ravel, Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530545/
https://www.ncbi.nlm.nih.gov/pubmed/31573603
http://dx.doi.org/10.1093/infdis/jiz499
_version_ 1783589589674360832
author Tamarelle, Jeanne
Ma, Bing
Gajer, Pawel
Humphrys, Mike S
Terplan, Mishka
Mark, Katrina S
Thiébaut, Anne C M
Forney, Larry J
Brotman, Rebecca M
Delarocque-Astagneau, Elisabeth
Bavoil, Patrik M
Ravel, Jacques
author_facet Tamarelle, Jeanne
Ma, Bing
Gajer, Pawel
Humphrys, Mike S
Terplan, Mishka
Mark, Katrina S
Thiébaut, Anne C M
Forney, Larry J
Brotman, Rebecca M
Delarocque-Astagneau, Elisabeth
Bavoil, Patrik M
Ravel, Jacques
author_sort Tamarelle, Jeanne
collection PubMed
description We characterized the composition and structure of the vaginal microbiota in a cohort of 149 women with genital Chlamydia trachomatis infection at baseline who were followed quarterly for 9 months after antibiotic treatment. At time of diagnosis, the vaginal microbiota was dominated by Lactobacillus iners or a diverse array of bacterial vaginosis–associated bacteria including Gardnerella vaginalis. Interestingly, L. iners–dominated communities were most common after azithromycin treatment (1 g monodose), consistent with the observed relative resistance of L. iners to azithromycin. Lactobacillus iners–dominated communities have been associated with increased risk of C. trachomatis infection, suggesting that the impact of antibiotic treatment on the vaginal microbiota could favor reinfections. These results provide support for the dual need to account for the potential perturbing effect(s) of antibiotic treatment on the vaginal microbiota, and to develop strategies to protect and restore optimal vaginal microbiota.
format Online
Article
Text
id pubmed-7530545
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-75305452020-10-07 Nonoptimal Vaginal Microbiota After Azithromycin Treatment for Chlamydia trachomatis Infection Tamarelle, Jeanne Ma, Bing Gajer, Pawel Humphrys, Mike S Terplan, Mishka Mark, Katrina S Thiébaut, Anne C M Forney, Larry J Brotman, Rebecca M Delarocque-Astagneau, Elisabeth Bavoil, Patrik M Ravel, Jacques J Infect Dis Major Articles and Brief Reports We characterized the composition and structure of the vaginal microbiota in a cohort of 149 women with genital Chlamydia trachomatis infection at baseline who were followed quarterly for 9 months after antibiotic treatment. At time of diagnosis, the vaginal microbiota was dominated by Lactobacillus iners or a diverse array of bacterial vaginosis–associated bacteria including Gardnerella vaginalis. Interestingly, L. iners–dominated communities were most common after azithromycin treatment (1 g monodose), consistent with the observed relative resistance of L. iners to azithromycin. Lactobacillus iners–dominated communities have been associated with increased risk of C. trachomatis infection, suggesting that the impact of antibiotic treatment on the vaginal microbiota could favor reinfections. These results provide support for the dual need to account for the potential perturbing effect(s) of antibiotic treatment on the vaginal microbiota, and to develop strategies to protect and restore optimal vaginal microbiota. Oxford University Press 2020-02-15 2019-10-01 /pmc/articles/PMC7530545/ /pubmed/31573603 http://dx.doi.org/10.1093/infdis/jiz499 Text en © The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Major Articles and Brief Reports
Tamarelle, Jeanne
Ma, Bing
Gajer, Pawel
Humphrys, Mike S
Terplan, Mishka
Mark, Katrina S
Thiébaut, Anne C M
Forney, Larry J
Brotman, Rebecca M
Delarocque-Astagneau, Elisabeth
Bavoil, Patrik M
Ravel, Jacques
Nonoptimal Vaginal Microbiota After Azithromycin Treatment for Chlamydia trachomatis Infection
title Nonoptimal Vaginal Microbiota After Azithromycin Treatment for Chlamydia trachomatis Infection
title_full Nonoptimal Vaginal Microbiota After Azithromycin Treatment for Chlamydia trachomatis Infection
title_fullStr Nonoptimal Vaginal Microbiota After Azithromycin Treatment for Chlamydia trachomatis Infection
title_full_unstemmed Nonoptimal Vaginal Microbiota After Azithromycin Treatment for Chlamydia trachomatis Infection
title_short Nonoptimal Vaginal Microbiota After Azithromycin Treatment for Chlamydia trachomatis Infection
title_sort nonoptimal vaginal microbiota after azithromycin treatment for chlamydia trachomatis infection
topic Major Articles and Brief Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530545/
https://www.ncbi.nlm.nih.gov/pubmed/31573603
http://dx.doi.org/10.1093/infdis/jiz499
work_keys_str_mv AT tamarellejeanne nonoptimalvaginalmicrobiotaafterazithromycintreatmentforchlamydiatrachomatisinfection
AT mabing nonoptimalvaginalmicrobiotaafterazithromycintreatmentforchlamydiatrachomatisinfection
AT gajerpawel nonoptimalvaginalmicrobiotaafterazithromycintreatmentforchlamydiatrachomatisinfection
AT humphrysmikes nonoptimalvaginalmicrobiotaafterazithromycintreatmentforchlamydiatrachomatisinfection
AT terplanmishka nonoptimalvaginalmicrobiotaafterazithromycintreatmentforchlamydiatrachomatisinfection
AT markkatrinas nonoptimalvaginalmicrobiotaafterazithromycintreatmentforchlamydiatrachomatisinfection
AT thiebautannecm nonoptimalvaginalmicrobiotaafterazithromycintreatmentforchlamydiatrachomatisinfection
AT forneylarryj nonoptimalvaginalmicrobiotaafterazithromycintreatmentforchlamydiatrachomatisinfection
AT brotmanrebeccam nonoptimalvaginalmicrobiotaafterazithromycintreatmentforchlamydiatrachomatisinfection
AT delarocqueastagneauelisabeth nonoptimalvaginalmicrobiotaafterazithromycintreatmentforchlamydiatrachomatisinfection
AT bavoilpatrikm nonoptimalvaginalmicrobiotaafterazithromycintreatmentforchlamydiatrachomatisinfection
AT raveljacques nonoptimalvaginalmicrobiotaafterazithromycintreatmentforchlamydiatrachomatisinfection